| Acetyl-CoA metabolism supports multistep pancreatic tumorigenesis A Carrer, S Trefely, S Zhao, SL Campbell, RJ Norgard, KC Schultz, ... Cancer discovery 9 (3), 416-435, 2019 | 277 | 2019 |
| LSD1 inhibition promotes epithelial differentiation through derepression of fate-determining transcription factors S Egolf, Y Aubert, M Doepner, A Anderson, A Maldonado-Lopez, ... Cell reports 28 (8), 1981-1992. e7, 2019 | 64 | 2019 |
| MLL4 mediates differentiation and tumor suppression through ferroptosis S Egolf, J Zou, A Anderson, CL Simpson, Y Aubert, S Prouty, K Ge, ... Science Advances 7 (50), eabj9141, 2021 | 59 | 2021 |
| YAP1-mediated suppression of USP31 enhances NFκB activity to promote sarcomagenesis S Ye, MA Lawlor, A Rivera-Reyes, S Egolf, S Chor, K Pak, GE Ciotti, ... Cancer research 78 (10), 2705-2720, 2018 | 54 | 2018 |
| YAP1 enhances NF-κB-dependent and independent effects on clock-mediated unfolded protein responses and autophagy in sarcoma A Rivera-Reyes, S Ye, G E. Marino, S Egolf, G E. Ciotti, S Chor, Y Liu, ... Cell death & disease 9 (11), 1108, 2018 | 42 | 2018 |
| The unexpected noncatalytic roles of histone modifiers in development and disease Y Aubert, S Egolf, BC Capell Trends in Genetics 35 (9), 645-657, 2019 | 36 | 2019 |
| Targeting SERCA2 in organotypic epidermis reveals MEK inhibition as a therapeutic strategy for Darier disease SA Zaver, MK Sarkar, S Egolf, J Zou, A Tiwaa, BC Capell, JE Gudjonsson, ... JCI insight 8 (18), 2023 | 11 | 2023 |
| LSD1: a viable therapeutic target in cutaneous squamous cell carcinoma? S Egolf, BC Capell Expert opinion on therapeutic targets 24 (7), 671-678, 2020 | 9 | 2020 |
| MLL4 is a critical mediator of differentiation and ferroptosis in the epidermis S Egolf, J Zou, A Anderson, Y Aubert, K Ge, JT Seykora, BC Capell bioRxiv, 2021.05. 03.442432, 2021 | 2 | 2021 |
| 394 LSD1 is a critical mediator of epidermal development, homeostasis, and oncogenesis N Kuprasertkul, C D'souza, C Magahis, S Prouty, S Egolf, ... Journal of Investigative Dermatology 144 (8), S68, 2024 | | 2024 |
| 1397 LSD1 is critical for epidermal development and skin barrier formation N Kuprasertkul, S Egolf, C Magahis, C D'souza, J Zou, D Brennan-Crispi, ... Journal of Investigative Dermatology 143 (5), S239, 2023 | | 2023 |
| 321 A human tissue model of Darier disease reveals MEK as a novel therapeutic target downstream of SERCA2 deficiency SA Zaver, M Sarkar, A Tiwaa, J Zou, S Egolf, B Capell, J Gudjonsson, ... Journal of Investigative Dermatology 143 (5), S55, 2023 | | 2023 |
| 788 Ferroptosis enhances epidermal cornification through transcriptional and metabolic reprogramming N Kuprasertkul, C Magahis, S Egolf, CL Simpson, C Mesaros, KE Wellen, ... Journal of Investigative Dermatology 143 (5), S135, 2023 | | 2023 |
| 449 Investigating the role of ferroptosis in epidermal differentiation N Kuprasertkul, S Egolf, J Zou, A Anderson, CL Simpson, K Ge, ... Journal of Investigative Dermatology 142 (8), S76, 2022 | | 2022 |
| 451 Modeling darier disease using gene-edited human keratinocytes and organotypic epidermis to identify therapeutic targets CL Simpson, M Sarkar, S Egolf, J Zou, BC Capell, JE Gudjonsson Journal of Investigative Dermatology 142 (8), S77, 2022 | | 2022 |
| The Mll4-Lsd1 Epigenetic Axis Regulates Epidermal Differentiation And Ferroptosis: Implications For Skin Cancer And Disease SA Egolf University of Pennsylvania, 2022 | | 2022 |
| 319 Epigenetic enhancer regulation in epithelial development and carcinogenesis S Egolf, Y Aubert, A Anderson, Y Lan, A Maldonado-Lopez, C Simpson, ... Journal of Investigative Dermatology 139 (5), S55, 2019 | | 2019 |
| Abstract B21: YAP1-mediated circadian oscillation in sarcoma G Marino, S Egolf, S Ye, K Pak, J Shah, A Rivera-Reyes, S Chor, ... Clinical Cancer Research 24 (2_Supplement), B21-B21, 2018 | | 2018 |
| Abstract B07: Regaining epigenetic control of the Hippo pathway to inhibit sarcomagenesis S Ye, K Pak, J Shah, S Chor, S Egolf, G Marino, TSK Eisinger-Mathason Clinical Cancer Research 24 (2_Supplement), B07-B07, 2018 | | 2018 |
| Regaining epigenetic control of the Hippo pathway to inhibit sarcomagenesis S Ye, K Pak, J Shah, S Chor, S Egolf, G Marino, TS Eisinger-Mathason CLINICAL CANCER RESEARCH 24 (2), 58-59, 2018 | | 2018 |
